Food Economics Division, USDA Economic Research Service, Washington, District of Columbia.
Department of Epidemiology, Colorado School of Public Health, Aurora, Colorado.
Foodborne Pathog Dis. 2020 Mar;17(3):172-177. doi: 10.1089/fpd.2019.2664. Epub 2019 Oct 9.
Cost of foodborne illness (CoFI) estimates provide estimates of the overall impact of foodborne illnesses, including hospitalizations, long-term complications, and deaths. CoFI estimates are needed in countries that require cost-benefit analysis as part of the process of adopting new regulations, as is the case in the United States. Monetary estimates of the impact of disease also provide a meaningful way of communicating with the public about the impact of foodborne disease. In 2014, researchers at the U.S. Department of Agriculture, Economic Research Service (ERS), published CoFI estimates for 15 pathogens that account for roughly 95% of illnesses and deaths from the 31 major foodborne pathogens included in the Centers for Disease Control and Prevention (CDC) foodborne disease incidence estimates. ERS is currently updating their estimates to include all 31 known pathogens and unspecific agents included in CDC incidence estimates. CoFI estimates are based on quantitative models of the health outcomes people experience as a result of these illnesses and an assessment of the costs associated with these health outcomes. Research on the incidence of foodborne disease provides a starting point for this disease modeling, but it usually must be supplemented by other additional synthesis of research on acute complications and long-term health outcomes of different foodborne diseases. As part of its current work revising CoFI estimates, ERS convened a workshop attended by leading foodborne disease public health scientists to discuss how changes in scientific research on the incidence and outcomes of foodborne illnesses should inform the next revision of ERS's CoFI estimates. This article presents a summary, based on discussion at this workshop, of the state of scientific research available to inform updated economic modeling of the CoFI in the United States.
食源性疾病成本（CoFI）估计数提供了食源性疾病总体影响的估计数，包括住院治疗、长期并发症和死亡。需要对那些要求进行成本效益分析的国家进行 CoFI 估计，因为这是美国的情况。疾病影响的货币估计数还为与公众就食源性疾病的影响进行沟通提供了一种有意义的方式。2014 年，美国农业部经济研究局（ERS）的研究人员发布了对造成食源性疾病的 31 种主要病原体中约 95%的疾病和死亡的 15 种病原体的 CoFI 估计数。ERS 目前正在更新其估计数，以纳入所有 31 种已知病原体和疾病预防控制中心（CDC）食源性疾病发病率估计数中包含的非特异性病原体。CoFI 估计数基于人们因这些疾病而经历的健康结果的定量模型以及与这些健康结果相关的成本评估。食源性疾病发病率的研究为这种疾病建模提供了一个起点，但通常必须辅以其他有关不同食源性疾病急性并发症和长期健康结果的研究的综合分析。作为其修订 CoFI 估计数的当前工作的一部分，ERS 召集了一次研讨会，邀请了领先的食源性疾病公共卫生科学家参加，讨论食源性疾病发病率和结果方面的科学研究变化应如何为 ERS 的下一次 CoFI 估计数修订提供信息。本文基于该研讨会的讨论，总结了可用于为美国 CoFI 的更新经济建模提供信息的现有科学研究状况。
